2017 Emerging Tumor Marker Testing Technologies and Strategic Profiles of Leading Suppliers
This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for tumor markers technologies. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.
The report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 185 pages
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.